Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Jewelegance sponsors AITA under-10 tennis tournament, committed to promoting sports Business
  • Inspired By Ancient Royal Beauty Rituals Relying On Natural Ingredients, Aneesh Fatima Launches Limelush Organics Lifestyle
  • Carnival Empire: Fun World Vadodara Unveils 365 Days of Non-Stop Fun Business
  • Pratham Daayitva Foundation launches Azaadi Ka Amrit Mahotsav by introducing Action Agenda 2024 Press Release
  • BigBloc Construction Ltd reports Revenue from Operations of Rs. 67.32 crore in Q2FY26, rise of 30.3% Y-o-Y Business
  • IIT Bombay and Washington University in St. Louis inaugurated 9th Cohort of Joint Executive MBA Program on 17th Jan 2024 Education
  • “The Affairs of Baxiganj” by Subhobroto Mazumder Lifestyle
  • Navitha Kallamadi’s Curious Panda Launches Mindfulness Planners, Achieves Rs 1.4 Crore Revenue Business

A birth defect in his spine and now a rare disease! 15-month old Nirvaan needs INR 17.5 cr to battle SMA

Posted on February 20, 2023 By

Mumbai (Maharashtra) [India], February 20: When a child is born, it is an occasion of happiness for everyone around. Sadly for the Mumbai-based Menon family, the joy lasted only for moments until they realised their beloved son Nirvaan was born with a birth defect- Congenital Scoliosis. Later during tests, he was diagnosed with a rare genetic disorder- Spinal Muscular Atrophy (SMA) – Type 2. This deadly disease has taken away his ability to eat, walk or breathe. The family has joined hands with the crowdfunding platform ImpactGuru.com and is raising INR 17.5 crores for their son’s treatment.

Nirvaan suffers from Spinal Muscular Atrophy (SMA) Type-2, and his condition is progressive, which means that with each passing day, his condition worsens. To help him battle this disorder, the gene therapy that shows hope is Zolgensma. To avail of this therapy, the child should be within the age limit of 2 years. Hence, it is necessary to fight against the clock and save Nirvaan’s life.

“Spinal Muscular Atrophy, a disease we had never heard of, has held our child under its clutches. We are more than willing to take all steps and knock at all doors that can help our Nirvaan. Because INR 17+ crores is a huge amount for any middle-class family to afford, we cannot lose our beloved child. Every contribution made will help us give Nirvaan his childhood back,” said Sarang, Nirvaan’s father.

What is SMA-2?

Spinal Muscular Atrophy – Type 2 or SMA-2 is a genetic neuromuscular disorder that affects the nerve cells that control voluntary muscles (motor neurons). If not treated, the progressive muscles become weak and eventually restrict any muscular movement. Babies with SMA-2 can sit without support. However, they cannot walk or stand unassisted.

The raised amount on Impact Guru, an online medical fundraising platform, will be used for Nirvaan’s ongoing treatment and dose of Zolgensma Therapy.

The single highest donation received on the crowdfunding campaign in INR is approximately 1 crore. All details are mentioned in the fundraiser link: (https://www.impactguru.com/fundraiser/help-nirvaan-a-menon)

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business Tags:Business

Post navigation

Previous Post: ORRA Jewellery outshines all others by winning 5 million Hearts this Valentine’s Day
Next Post: Mr. Digant Sharma, CMD of Francture Brands has done Sole-tie-up with renowned Russian Refinery for Crude oil, LPG, LNG, Diesel and more

Related Posts

  • Axita Cotton Limited has Received whopping order worth USD 3.28M from Bangladesh Business
  • Bodhi Tree Partners Amit Khan Content Hub for Original OTT, TV Projects Business
  • At Spiel®, the Focus Is On Providing The Best Wealth Management Solutions To Move Towards Perfection Business
  • How Can Doctors Leverage The Power of Local Business Listings From FINNDIT? Business
  • Asomiya Pratidin & Pratidin Time Presents The Conclave 2022 Business
  • FOIP with Investors Clinic to Raise INR 500 Crore in Tier-2 Cities in 2026 with a Clear Focus on Managed Farmland & Technology Business

Recent Posts

  • What If Movies Could Smell and Taste? The Future of Digital Flavor and Sensory Cinema
  • Automation Expo 2026 to Spotlight AI, Smart Manufacturing, and Industrial Innovation in Mumbai
  • Chandan Healthcare Limited Q1 FY27 Operational Update: Operating Income Up 35.64% YoY to ₹48.67 Cr; Pharmacy Up 13.69% YoY to ₹32.33 Cr
  • YAAP Digital Announces Leadership Transition; Appoints Raj Nayak as Chairman & Managing Director
  • BIRLA AIRCON Earns Bureau of Indian Standards Appreciation for Quality Excellence, Records Over 700% Growth

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • A phygital platform to serve the banking needs of low-income groups launched by Spay India Business
  • 15.43 Lakh New Workers Enrolled in ESI Scheme: A Major Milestone in Social Security National
  • Redbull DYS India witnesses “Memphis Jookin” dance style for the very first time brought by Anubhav Dadhwal aka Imaganimatrix Entertainment
  • AECC launches an unconventional circus-inspired campaign that focuses on prioritising students in their study abroad adventure Business
  • Driving Innovation and Excellence: The Visionary Leadership of Vijay Rengarajan in Insurance Product Development Business
  • RLG Announces Awareness and Collection Drive in Delhi Under Flagship Clean to GreenTM (C2G) Campaign Press Release
  • Indian Cotton Textiles Industry to get major orders at IND TEXPO 2022 Business
  • Design as a Career Language: JAIN University’s Creative Edge Education

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme